Le Lézard
Classified in: Business
Subject: INO

Thinking about buying stock in ATIF Holdings, SoundHound AI, Halliburton, Moderna, or Co-Diagnostics?


NEW YORK, Jan. 4, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATIF, SOUN, HAL, MRNA, and CODX.

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

  1. ATIF: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATIF&prnumber=202401044
  2. SOUN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=SOUN&prnumber=202401044
  3. HAL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=HAL&prnumber=202401044
  4. MRNA: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=MRNA&prnumber=202401044
  5. CODX: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CODX&prnumber=202401044

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.

SOURCE InvestorsObserver


These press releases may also interest you

at 16:05
Vertex Pharmaceuticals Incorporated today reported consolidated financial results for the first quarter ended March 31, 2024, and reiterated full year 2024 financial guidance. "Vertex delivered a strong start to 2024 with 13 percent product...

at 16:05
Enanta Pharmaceuticals, Inc. , a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today reported financial results for its fiscal second quarter ended March 31, 2024. "At...

at 16:05
FIS® , a global leader in financial technology, today reported its first quarter 2024 results. "We are off to a very strong start in 2024. This marks the fifth straight quarter of exceeding our financial outlook, and we are pleased with the...

at 16:05
Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported results for its fiscal third quarter ended March 30, 2024. "Lumentum is well-positioned to capitalize on surging cloud data center demand driven by the exponentially increasing...

at 16:05
CVD Equipment Corporation , a leading provider of chemical vapor deposition and thermal process equipment, today announced that it will release its financial results for the first quarter ended March 31, 2024 after the market closes on Monday, May...

at 16:05
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and recent operational results for the quarter...



News published on and distributed by: